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Objective: The aim of this study was to explore the role of cytokines in the pathogenesis of
hemorrhagic fever with renal syndrome (HFRS).
Methods: Double-antibody sandwich ELISA was used to determine serum interleukin (IL)-6,
urine tumor necrosis factor (TNF), IL-6, and IL-8 levels in 56 patients with HFRS.
Results: Serum IL-6, urine TNF, IL-6, and IL-8 concentrations in HFRS patients were signif-
icantly higher than those in the control group (p<0.001). The concentrations increased at
fever stage, then continued to increase during the hypotension stage and peaked at the olig-
uria stage. The concentrations of serum IL-6, urine TNF, IL-6, and IL-8 increased according to
the severity of the disease, and differed greatly among different types of the disease. Serum
IL-6 had remarkable relationshipswith serum speciﬁc antibodies. It was positively related to
serum 2-microglobulin (2-MG), blood ureanitrogen (BUN), and creatinine (Cr). Signiﬁcant
positive relationships were also found both between urine IL-6 and TNF, and between IL-6
and IL-8 (r = 0.5768, p<0.05; r = 0.3760, p<0.01).
Conclusion: TNF, IL-6, and IL-8 were activated during the course of the disease. IL-6 was asso-
ciated with the immunopathological lesions caused by the hyperfunction of the humoralimmune response. IL-6, IL-8 and TNF were involved in renal immune impairment. Deter-
mining them might, to a certain extent, be useful in predicting the prognosis and outcome
of patients with HFRS.
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to increase during the hypotension stage, reaching their peak
during the oliguria stage. Therefore, serum IL-6 and urine IL-6
were parallel (r = 0.76, p< 0.01).
Table 1 – Dynamic change of serum IL-6 in patients with
HFRS during each stage (x¯ ± s).
Stage Number of cases IL-6 (ng.L−1) p-value
Normal control group 20 85 ± 25
Fever stage 37 586 ± 125 <0.001*
Hypotension stage 26 1043 ± 217 <0.01*
Oliguria stage 54 1209 ± 258 <0.05*528 braz j infect d
with HFRS were detected by ELISA. The relationships of IL-6
with serum speciﬁc IgM and IgG antibodies, and with 2-
microglobulin (2-MG), respectively, were also analyzed to
explore the role of IL-6 in the pathogenesis of HFRS.
Methods and patients
Subjects
The subjects were 56 inpatients with positive HFRS-speciﬁc
IgM and IgG antibodies, admitted to the Department of Infec-
tious Diseases of this hospital and of the Xi’an Infectious
Disease Hospital from 1992 to 2003. This study was con-
ducted in accordance with the Declaration of Helsinki, with
approval from the Ethics Committee of the First Afﬁliated
Hospital of the Medical School of the Xi’an Jiaotong Univer-
sity. An informed consent was obtained from all participants.
The diagnosis and classiﬁcation were made according to the
standard adopted during the National Epidemic Hemorrhagic
Fever Symposium held in Nanjing in 1986. From the day the
patients were admitted to the hospitals, blood and urine sam-
ples were collected twice a day, and a total of 195 blood
samples and 186 urine samples were obtained, which were
stored at negative 20 ◦C. The control group consisted of 20
healthyblooddonors. TheirHFRS speciﬁc IgMand IgGantibod-
ies and hepatitis virus infection indicators were all negative.
Reagents
IL-6, TNF, IL-8 monoclonal antibodies, standard samples, and
negative controls were provided by Professor Jin Boquan from
the Department of Immunological Teaching and Research of
the Fourth Military University. Fluorescent splits were made
by the Shanxi Preventive Medicine Research Medical Insti-
tute. Fluorescent indicators (isosulfocyanic acid) containing
IgG and IgM extracted from sheep blood and 2-MG kits were
provided by the Shanghai Vaccine and Serum Institute.
Methods
Total serum globulins were determined by biuret. Speciﬁc
IgM and IgG were detected by indirect immune ﬂuorescence,4
and B2-MG by speciﬁc radiation ﬂuorescence, according to
the speciﬁcations of the kits. IL-6, IL-8, and TNF were deter-
mined by ELISA. The ELISA plate (96-well plate for ELISA
reaction; Maxisorp, Denmark) was coated with 100L/well of
diluted capture antibody, incubated at 4 ◦C for 48hours. On
the third day, the plate was removed from 4 ◦C and rinsed
three times with wash buffer, for 5min each wash step. The
standard curve and samples were added with 100L/well and
incubated at 37 ◦C for 2h. After the plate was washed three
times, diluted biotinylated detection antibodies were dripped
with 100L/well, and incubated at 37 ◦C for 1h. The plate
was washed three times. ABTS was added with 100L/well,
and incubated at 37 ◦C for 30min. The absorption value (OD
410nm) was read by microplate spectrophotometer.12;16(6):527–530
Statistical analysis
Results were expressed by the mean and standard deviation.
Sample mean comparison was made using Student’s t-test,
square analysis and linear relative analysis. A p-value <0.05
was considered signiﬁcant.
Results
Characteristics of the participants
A total of 76 unrelated Chinese Han subjects (56 inpatients
with HFRS, and 20 healthy control individuals) were included
in the study. The patients were an average of 36.8 (18-61) years
old, and consisted of 46 males and 10 females. The healthy
controls had an average age of 34.9 (24∼55) years old, and
50% of them were males. All of the patients detected by RT-
PCR were positive for viral RNA. In accordance with the 1986
Nanjing standard, ten cases were diagnosed as mild, 20 as
moderate, 18 as severe, and eight as very severe. One of the
very severe patients died of a lung infection, and the others
survived after treatment.
Change of serum IL-6
In the fever stage, the concentration of serum IL-6 in patients
with HFRS was higher than that in control group (p<0.001).
The concentration of serum IL-6 continued to increase dur-
ing hypotension stage, reached its peak during the oliguria
stage, decreased signiﬁcantly during the polyuria stage, and
remained higher than the controls during the convalescent
stage. Fifteen patients with HFRSwere tested at the same time
and showed the same pattern of change (Table 1).
Changes of urine IL-6, IL-8, and TNF
As shown in Fig. 1, the concentration of urine TNF in patients
with HFRS increased remarkably during the fever stage,
reached its peak during the hypotension stage, decreased dur-
ing the oliguria stage, and declined signiﬁcantly during the
polyuria stage. It also showed that the concentrations of IL-
6 and IL-8 increased during the fever stage, and continuedPolyuria stage 50 372 ± 81 <0.005*
Convalescent stage 28 170 ± 36 >0.05
∗ vs control group.
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Table 2 – Concentrations of urine IL-6, IL-8, and TNF in patients with HFRS in each type (x¯ ± s).
Type Number of cases TNF (ng.L−1) IL-6 (ng.L−1) IL-8 (ng.L−1)
Fever stage Hypotension stage Oliguria stage Polyuria stage Convalescent stage
Mild 5 0 0 8 3 126 ± 53 147 ± 58 187 ± 69
Moderate 15 10 25 12 6 266 ± 87 301 ± 103 382 ± 108
Severe 12 12 20 17 9 329 ± 95 411 ± 102 482 ± 123
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elationships between the urine TNF, IL-6 and IL-8
ith increasing severity of the disease, the concentra-
ions of urine TNF, IL-6, and IL-8 in patients with HFRS
ncreased. The concentration of TNF differed signiﬁcantly
n each type. Except in severe and dangerous types, both
he concentrations of IL-6 and IL-8 differed signiﬁcantly in
ther types (p<0.05). IL-6 was positively related to both TNF
nd IL-8 (r = 0.5609, p<0.005; r = 0.3794, p<0.01, respectively)
Table 2).
erum IL-6 and speciﬁc IgM and IgG
uring the course of HFRS, the concentration of IL-6 increased
n the third day, peaked on the sixth day, and decreased sig-
iﬁcantly during the eighth and 12th day. The concentrations
f IgM and IgG increased on the third day, and peaked on
he ninth and 11th days, respectively. From the ninth day
nwards, the concentration of IgM decreased signiﬁcantly.
he concentration of IgG remained high. The concentra-
ion of IL-6 was positively related to IgM decrease (r = 0.42,
< 0.05).
elationships between IL-6 and serum globulins
erum globulins increased during the fever stage and peaked
uring the oliguria stage. Serum globulins were positively
elated to IL-6 (r = 0.51, p< 0.05).
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ig. 1 – Change of urine IL-6, IL-8, and TNF among different
roups.4 411 ± 114 439 ± 136 539 ± 16
Relationships between serum IL-6 and ˇ2-MG, BUN and
Cr
116 samples collected during the fever, hypotension, and olig-
uria stages were analyzed. The analysis demonstrated that
serum IL-6 was positively related to 2-MG, BUN, and Cr
(r = 0.56, 0.46, 0.61, respectively). During the fever, hypoten-
sion, and oliguria stages, IL-6 was positively related to 2-MG
(r = 0.53, 0.56, 0.67; p < 0.01).
Relationships between IL-6, and IgG and ˇ2-MG
As shown in Table 3, with increasing severity of the disease,
the concentration of IL-6 increased. The concentration inmild
type differed greatly from that inmoderate type, and also from
those in severe and very severe types (p<0.005). The concen-
trations of 2-MGand speciﬁc IgG differed signiﬁcantly in each
type (p<0.01∼0.005). The three were highly related. The rela-
tive coefﬁcients between IL-6 and 2-MG were 0.60, 0.66, 0.63,
and 0.61 in mild, moderate, severe, and very severe, respec-
tively. The relative coefﬁcients between IL-6 and IgGwere 0.58,
0.50, 0.55, and 0.52 in mild, moderate, severe, and very severe
types respectively. The relative coefﬁcients between 2-MG
and IgG were 0.54, 0.5816, 0.60 and 0.56 in mild, moderate,
severe, and very severe types respectively.
Discussion
IL-6, IL-8, and TNF are generated by multiple cells. IL-6 has
immunomodulatory functions, such as differentiating B-cells
to generate antibodies. The primary function of IL-8 is the
induction of chemotaxis in its target cells. TNF can cause local
inﬂammation and multiple-organ impairments.
The study showed that, at the fever stage, the concentra-
tion of serum IL-6 in patients with HFRS was higher than
that of the control group, peaking in the oliguria stage,
which was in accordance with the progression of the dis-
ease. The possible reason the concentration of serum IL-6
in patients with HFRS increased at early stage is that, after
the HFRS virus infects the body, it proliferates in immune
cells, ﬁbroblast cells, epidermic cells, and intercapillary cells.
It activates these cells, enabling them to generate more IL-
6.5 At the oliguria stage, hepatic and renal dysfunction can
cause difﬁculty in eliminating and excreting IL-6, leading
to the peak of serum IL-6 concentration in patients with
HFRS.
The concentrations of urine IL-6, IL-8, and TNF increased
signiﬁcantly at the fever stage. The concentration of TNF
peaked in the hypotension stage, and decreased from the
530 braz j infect d i s . 2012;16(6):527–530
Table 3 – Concentrations of IL-6, IgG and 2-MG in patients with HFRRS in each type (x¯ ± s).
Type Number of cases IL-6 (ng.L−1) 2-MG (mg.L−1) IgG (lgGMT)
Mild 10 232 ± 99 14 ± 7 1.36 ± 0.62
Moderate 20 627 ± 26 120 ± 12 1.94 ± 0.96
4 ± 2
9 ± 3
r
respectable Dukes’ C colorectal cancer indicate high risk forSevere 18 88
Very severe 8 119
oliguria stage onwards. The concentrations of IL-6 and IL-8
peaked in the oliguria stage, and decreased signiﬁcantly in
the polyuria stage. The concentration of serum IL-6 was pos-
itively related to that of urine IL-6. The possible reason for
the increase of urine cellular factors is that serum cytokines
increased and were more excreted in the urine.6,7 After the
HFRS virus infects the body, it proliferates in mesangial cells,
tubular epithelium cells, and interstitial cells, causing an
increase of activated cells that can produce cellular factors.
The antibodies to HFRS virus could be detected in mono-
nuclear cells, neutrophils, epidermic cells, andmultinucleated
giant cells, all of which had a greater ability to produce cel-
lular factors. In renal tubules, hyperactive TNF could cause
local inﬂammation, which is related to immune impairments
of renal function. IL-6 and IL-8 participate in the formation
of immune complexes at the base membrane of the renal
glomerulus and in the invasion of inﬂammatory cells in liver.
It can be concluded that immune impairmentsmediated by IL-
6, IL-8, and TNF play an important role in renal impairments.
It can also be concluded that IL-6 was positively related to IL-8
and TNF, which showed that the three might derive from the
same cell.8
The concentrations of serum IL-6 and urine IL-6, IL-8, and
TNF in HFRS patients increasedwith the increasing severity of
the disease, and differed signiﬁcantly in each type. This phe-
nomenon showed that the concentrations of IL-6, IL-8, and
TNF were positively related to clinical type, so determination
of the concentrations of serum IL-6 and urine IL-6, IL-8, and
TNF can help predict prognosis and outcome of the patients.
In each type, IL-6 was positively related to IgG, demonstrat-
ing that IL-6 was related to hyperactivity of humoral immune
reaction, leading to immune-mediated pathological damages.
On the sixth day, the concentration of IL-6 reached its peak.
On the ninth and 11th days, the concentrations of IgM and IgG
reached their peaks, respectively. Thedata indicate thathyper-
active IL-6 was closely related to the increase of lymphocytes,
to atypical lymphocytes (at different stages of development)
in patients’ blood, and to that of plasma cell in marrow.9
The data also implied that the change of IL-6 was in accor-
dance with that of plasma cells in blood and marrow, and
the increased production of IgG and IgMantibodies. Therefore,
IL-6 was closely related to the increase of speciﬁc antibodies
during the course of HFRS. The positive relationship between
the concentration of IL-6 and that of blood globulins showed
that the number of immune globulins generated by -cells
19 931 ± 28 2.52 ± 1.12
7 660 ± 37 2.95 ± 1.43
signiﬁcantly depended on the concentration of IL-6. 2-MG, an
ideal and speciﬁc indicator of renal failure index, is inversely
related to RGI.10 IL-6 was positively related to 2-MG, Bun, and
Cr. During the ﬁrst three stages, IL-6 was positively related to
2-MG. In each type, IL-6 was also positively related to 2-
MG. These facts demonstrate that IL-6 participated in renal
immune-mediated impairment, leading to the change of RGI
and renal function.
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